ArticleBMC cancer2021

Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt/β-catenin signal pathway in prostate cancer cells.

Ying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.